Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By afschroeder • July 8, 2025

Hashmi TM, Shafiq A, Zia R, Ashraf H, Burhan M, Ahmed M, Mesmar A, Ahmed R, Fonarow GC. Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2025 Jul 5:108392. doi: 10.1016/j.jstrokecerebrovasdis.2025.108392. Epub ahead of print. PMID: 40623511.

Tags: alteplase, Cardiology/Epi, Publications, recombinant human pro-urokinase, stroke, thrombolytic therapy

Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase in Aeromonas spp

von Bredow B, Trejo M, Ward KW, Trieu KP, Santellan CA, Garner OB, Yang S, Chandrasekaran S. Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]

Effects of fenofibrate on angiopoietin-like 3/4/8 proteins and apolipoprotein A5

Yang Y, Smith S, Chen YQ, Li H, Zhen EY, Sloan JH, Siegel RW, Qian Y, Wen Y, Jung H, Scheithauer JL, Kersten S, Young[...]